Table 1.
Characteristic | With AKI (n = 25) | Without AKI (n = 22) | P |
---|---|---|---|
Age (years), mean ± SD | 44 ± 17 | 42 ± 12 | 0.59 |
Gender, male/female | 12/13 | 10/12 | 1.00 |
Oseltamivir ≥48 hours after symptom onset, yes/no | 20/5 | 18/4 | 1.00 |
Days from hospitalization to ICU admission, median (range) | 1 (0.5 to 2.5) | 1 (0 to 2) | 0.33 |
Comorbidities | |||
previous renal dysfunction, yes/no | 2/23 | 3/19 | 0.65 |
chronic respiratory disease, yes/no | 6/19 | 5/17 | 1.00 |
immunosuppression, yes/no | 4/21 | 8/14 | 0.18 |
hypertension, yes/no | 5/20 | 1/21 | 0.19 |
diabetes, yes/no | 4/21 | 1/21 | 0.35 |
obesity,c yes/no | 5/20 | 4/18 | 1.00 |
pregnancy, yes/no | 2/11 | 0/12 | 0.48 |
At ICU admission | |||
mechanical ventilation, yes/no | 19/6 | 12/10 | 0.01 |
vasopressor use, yes/no | 19/6 | 3/19 | <0.001 |
APACHE II score, mean ± SD | 17 ± 5a | 12 ± 7b | 0.008 |
PaO2/FiO2 ≤ 200, yes/no | 18/6 | 3/15 | <0.001 |
Evolution | |||
length of hospital stay (days), median (range) | 17 (8.5 to 33) | 6 (3 to 15) | 0.001 |
death, yes/no | 9/16 | 0/22 | 0.001 |
PaO2, arterial oxygen tension; FiO2, fraction of inspired oxygen.
n = 24,
n = 20,
No morbid obesity.